FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...